$23.76
+0.57 (+2.46%)
Performance
1D
—
1W
—
1M
—
3M
-29.07%
6M
-30.16%
1Y
+217.86%
YTD
-19.40%
Open$23.96
Previous Close$23.19
Day High$24.98
Day Low$22.18
52W High$55.65
52W Low$5.18
Volume—
Avg Volume73.0K
Market Cap3.66B
P/E Ratio593.92
EPS$0.14
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$29.64
Below
SMA 200
$30.05
Below
RSI (14)
49.5
Neutral
Trend
Death Cross
Bearish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 27.65M | 22.53M | 1.84B |
| Net Income | 8.02M | 5.88M | -354,337,532 |
| Profit Margin | 29.0% | 27.5% | -19.2% |
| EBITDA | 6.80M | 5.26M | -454,323,212 |
| Free Cash Flow | — | — | -249,462,362 |
| Rev Growth | +22.7% | +22.7% | +17.6% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |